It signals to your brain that you're full, slows digestion, and helps regulate blood sugar levels
Over the past few decades several hormones from various body systems involved in food intake have been targeted as potential treatments for obesity and diabetes, but GLP-1 seems to be the one thats risen to the top, at least for pharmacotherapy, says Scott Kanoski, a behavioral neuroscientist and professor at the University of Southern California
Private and public payers, as well as patients, want access and have been calling for lower list prices, Jamey Millar, executive vice president for US operations of Novo Nordisk, said in the announcement
Conversion charts are invaluable for understanding dose relationships
4, Supplementary Table 1)
Enrolled participants had a mean baseline A1C of 8.1% in both treatment groups